| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |